Silvia Rossi

Silvia Rossi

Auto-generated profile, based on publicly available information

Silvia Rossi

Universitá Tor Vergata

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2009 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
Diego CentonzeDiego Centonze
Diego Centonze
LMLuca Muzio
Luca Muzio
SRSilvia Rossi
Silvia Rossi
FCFrancesca Cavasinni
Francesca Cavasinni
VCValentina De Chiara
Valentina De Chiara
GMGianvito Martino
Gianvito Martino
Neurodegeneration is the irremediable pathological event occurring during chronic inflammatory diseases of the CNS. Here we show that, in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis, inflammation is capable in enhancing glutamate transmission in the striatum and in promoting synaptic degeneration and dendritic spine loss. These alterations occur early in the disease course, are independent of demyelination, and are strongly associated with massive release of tumor necrosis factor-α from activated microglia. CNS invasion by myelin-specific blood-borne immune cells is the triggering event, and the downregulation of the early geneArc/Arg3.1, leading to the abnormal expression and phosphorylation of AMPA receptors, represents a culminating step in this cascade of neurodegenerative events. Accordingly, EAE-induced synaptopathy subsided during pharmacological blockade of AMPA receptors. Our data establish a link between neuroinflammation and synaptic degeneration and calls for early neuroprotective therapies in chronic inflammatory diseases of the CNS.

20 January 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
Mauro MaccarroneMauro Maccarrone
Mauro Maccarrone
SRSilvia Rossi
Silvia Rossi
MBMonica Bari
Monica Bari
VCValentina De Chiara
Valentina De Chiara
FFFilomena Fezza
Filomena Fezza
Diego CentonzeDiego Centonze
Diego Centonze

7 June 2011 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SRSilvia Rossi
Silvia Rossi
RFRoberto Furlan
Roberto Furlan
VCValentina De Chiara
Valentina De Chiara
CMCaterina Motta
Caterina Motta
VSValeria Studer
Valeria Studer
Diego CentonzeDiego Centonze
Diego Centonze

11 July 2007 in Brain
Verified
Journal Article
Open access
PDF file
Diego CentonzeDiego Centonze
Diego Centonze
MBMonica Bari
Monica Bari
SRSilvia Rossi
Silvia Rossi
CPChiara Prosperetti
Chiara Prosperetti
RFRoberto Furlan
Roberto Furlan
MMMauro Maccarrone
Mauro Maccarrone
The ability of cannabinoids to modulate both inflammatory and degenerative neuronal damage prompted investigations on the potential benefits of such compounds in multiple sclerosis (MS) and in animal models of this disorder. Here we measured endocannabinoid levels, metabolism and binding, and physiological activities in 26 patients with MS (17 females, aged 19–43 years), 25 healthy controls and in mice with experimental autoimmune encephalomyelitis (EAE), a preclinical model of MS. Our results show that MS and EAE are associated with significant alterations of the endocannabinoid system. We found that anandamide (AEA), but not 2-arachidonoylglycerol (2-AG), was increased in the CSF of relapsing MS patients. AEA concentrations were also higher in peripheral lymphocytes of these patients, an effect associated with increased synthesis and reduced degradation of this endocannabinoid. Increased synthesis, reduced degradation, and increased levels of AEA were also detected in the brains of EAE mice in the acute phase of the disease, possibly accounting for its anti-excitotoxic action in this disorder. Accordingly, neurophysiological recordings from single neurons confirmed that excitatory transmission in EAE slices is inhibited by CB1 receptor activation, while inhibitory transmission is not. Our study suggests that targeting the endocannabinoid system might be useful for the treatment of MS.

20 November 2009 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
Diego CentonzeDiego Centonze
Diego Centonze
LMLuca Muzio
Luca Muzio
SRS Rossi
S Rossi
RFRoberto Furlan
Roberto Furlan
GBG Bernardi
G Bernardi
GMG Martino
G Martino
Multiple sclerosis (MS) has been classically regarded as a disorder of the white matter of the central nervous system (CNS). However, early alterations of the neuronal compartment occurring in this disorder are partially independent of demyelination. Soluble inflammatory cytokines and glutamate have been proposed as major determinants of neurodegeneration in MS as well as in its experimental animal model, namely experimental autoimmune encephalomyelitis (EAE). The relationship between these two major determinants has been largely elusive. In recent years, unexpected connections have emerged between immune cells and soluble cytokines on the one hand, and synaptic transmission and neurodegeneration on the other. Neurophysiological recordings have recently shown that glutamate-mediated excitatory postsynaptic currents are enhanced during the early phase of EAE, because of altered expression and phosphorylation of AMPA receptors and the downregulation of the immediate early gene Arc/Arg3.1. The synaptic alterations occurring during neuroinflammatory diseases are largely mediated by inflammatory cytokines released from infiltrating T cells and from activated microglia, and are responsible, at least in part, for irreversible dendritic pathology. Collectively, the data covered in this review article suggest that CNS-confined inflammation in MS is associated with the release of soluble molecules, which are capable of altering excitatory synaptic transmission and, finally, of stimulating secondary neurodegenerative gray matter pathology.

1 October 2012 in Experimental Neurology
Verified
Journal Article
Closed access
NHNabila Haji
Nabila Haji
Georgia MandolesiGeorgia Mandolesi
Georgia Mandolesi
AGAntonietta Gentile
Antonietta Gentile
LSLucia Sacchetti
Lucia Sacchetti
Diego FresegnaDiego Fresegna
Diego Fresegna
Diego CentonzeDiego Centonze
Diego Centonze